POBA

DEVICE8 trials

Sponsors

Tryton Medical, Inc., Leonardo Bolognese, MD, Skane University Hospital, Jena University Hospital, Cagent Vascular LLC

Conditions

Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary ArteryCoronary Atherosclerosis of Native Coronary ArteryCritical Limb IschemiaCritical Limb Ischemia (CLI)Drug Coated BalloonFemoropopliteal DiseaseIntermittent ClaudicationIntracranial Atherosclerotic Stenosis

Phase 4

Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation

CompletedNCT01558505

Leonardo Bolognese, MDCritical Limb Ischemia

Start: 2010-11-30Updated: 2013-01-29

Unknown Phase

Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries

CompletedNCT01258972

Tryton Medical, Inc.Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary Artery, Coronary Atherosclerosis of Native Coronary Artery

Start: 2010-12-31End: 2016-10-31Updated: 2016-10-18

Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis

SuspendedNCT01558531

Leonardo Bolognese, MDPeripheral Arterial Disease

Start: 2010-01-31Updated: 2015-02-03

DEB ( Drug Eluting Balloon) in Crural Arteries and Critical Limb Ischemia

CompletedNCT02750605

Skane University HospitalPeripheral Vascular Diseases

Start: 2016-02-29End: 2022-08-30Updated: 2022-12-30

Systematic Review and Meta-Analysis on DCB vs. POBA in De-novo Femoropopliteal Disease

CompletedNCT02927574

Jena University HospitalIntermittent Claudication, Peripheral Arterial Disease

Start: 2016-07-31End: 2017-09-30Updated: 2020-03-10

Serranator Recoil Study

Cagent Vascular LLCCritical Limb Ischemia, Peripheral Arterial Disease

Start: 2021-11-15End: 2022-07-31Target: 20Updated: 2022-06-09

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

Active, not recruitingNCT06047964

B. Braun Medical International Trading Company Ltd.Intracranial Atherosclerotic Stenosis, Stroke

Start: 2023-03-23End: 2025-01-23Updated: 2024-10-21

DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial Disease

CompletedNCT07136883

Marc SirventCritical Limb Ischemia (CLI), Drug Coated Balloon, Femoropopliteal Disease +1

Start: 2020-09-25End: 2022-10-31Updated: 2025-08-29

Related Papers

Prospective Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus Conventional Balloon Angioplasty in Treating Below the Knee Arterial Lesions in Chronic Limb Threatening Ischemia: The CRURAL DEB Study.

2025-11-20

Visual estimation versus different quantitative coronary angiography methods to assess lesion severity in bifurcation lesions.

2017-08-2413 citations

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

2015-10-2856 citations

Comparison between two- and three-dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial.

2015-04-247 citations

A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.

2015-02-0180 citations

Inter-core lab variability in analyzing quantitative coronary angiography for bifurcation lesions: a post-hoc analysis of a randomized trial.

2015-02-0129 citations

Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.

2014-02-01102 citations

Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint

MD Conference Express2013-12-01